Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
about
Screening for Small Molecule Inhibitors of Statin-Induced APP C-terminal Toxic Fragment Production.Parallel evolution of genes controlling mitonuclear balance in short-lived annual fishesAPOE gene polymorphism in long-lived individuals from a central China population.Apolipoprotein E - A Multifunctional Protein with Implications in Various Pathologies as a Result of Its Structural FeaturesRole of the APOE polymorphism in carotid and lower limb revascularization: A prospective study from Southern Italy.Does selection for short sleep duration explain human vulnerability to Alzheimer's disease?New approach to generating insights for aging research based on literature mining and knowledge integration.Genetic susceptibility to cardiovascular disease and risk of dementia.Updated meta-analysis of the role of APOE ε2/ε3/ε4 alleles in frontotemporal lobar degeneration.Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.Psoriasis-associated vascular disease: the role of HDL.P2X7 Receptor and APOE Polymorphisms and Survival from Heart Failure: A Prospective Study in Frail Patients in a Geriatric UnitLipoprotein(a) Mass Levels Increase Significantly According to APOE Genotype: An Analysis of 431 239 Patients.The association of MPO gene promoter polymorphisms with Alzheimer's disease risk in Chinese Han population.Apolipoprotein E as a novel therapeutic neuroprotection target after traumatic spinal cord injury.Hidden heterogeneity in Alzheimer's disease: Insights from genetic association studies and other analyses.Molecular Mechanisms of the R61T Mutation in Apolipoprotein E4: A Dynamic Rescue.Apolipoprotein E4 causes early olfactory network abnormalities and short-term olfactory memory impairments.Multilocus Analysis of Genetic Susceptibility to Myocardial Infarction in Russians: Replication Study.Gene-based association study for lipid traits in diverse cohorts implicates BACE1 and SIDT2 regulation in triglyceride levels.FAK-ERK activation in cell/matrix adhesion induced by the loss of apolipoprotein E stimulates the malignant progression of ovarian cancer.Apolipoprotein E4 mediates insulin resistance-associated cerebrovascular dysfunction and the post-prandial response.Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of Evolocumab.Polymorphism and plasma levels of apolipoprotein E and the risk of aneurysmal subarachnoid hemorrhage in a Chinese population: a case-control study.Intake of 3 Eggs per Day When Compared to a Choline Bitartrate Supplement, Downregulates Cholesterol Synthesis without Changing the LDL/HDL Ratio.Identification of brain antigens recognized by autoantibodies in experimental autoimmune encephalomyelitis-induced animals treated with etomoxir or interferon-β.ApoE isoform leading to hypertriglyceridemia in new onset type 1 diabetes.In the Heart of the Amazon: Noncommunicable Diseases and Apolipoprotein E4 Genotype in the Riverine Population
P2860
Q30361852-F8246355-40C9-49A9-AE31-08DEF82B98F1Q33638908-D4BC40AF-6E37-4793-9B48-0A149E7FFDCBQ33789429-BA36AA89-4463-42A4-9022-78D8024301F3Q33813945-0C7148D1-AA1F-4B50-8891-060B53A0DF18Q36293981-C4407276-7772-4BE5-A4E5-205636EE4023Q37738358-C06B322C-7B52-4D7A-8DA0-45DBC55F59C8Q38619805-2986E7D1-761B-4820-946B-5E3370AA807BQ38757089-10CC01A3-F665-446D-AF82-6DB9406E4539Q38795201-98040E4A-43AE-41C4-A2C8-33CD027F01ACQ39380623-1FD1F936-482F-4A9B-8D16-C0A4FD383F3EQ41108229-49662E99-6CB0-4851-8BCF-CE9E9D1BDFAEQ41108747-A241EF07-E355-49B3-9A45-D40744AFAE21Q46239308-D9203011-8A0A-4B9D-A1DD-A8469CE1FCA7Q47108729-C7AEB378-83B3-46FB-BD5D-F8744F3D26FEQ47619892-71B1CE94-25CE-4715-B595-12274F89AF94Q47625969-9A989484-966F-4988-91E7-26471DF893C8Q47794190-731F2882-5F60-4139-BD69-A185FC1EC225Q48387166-E8BDB906-0A37-4DBC-A908-9A0AF90A5F1AQ49623528-C6FB11F0-9431-4404-B27D-3EBAA881F896Q49706131-3FA91FB7-D017-4596-AA63-62D4FD35AF58Q49843400-956ACE22-0369-400E-8CF9-C30B403E592CQ50035045-CADE917D-2D28-421A-AD94-4071428493E0Q51769247-415D0B81-4491-44E0-A61A-1646B65690A8Q54951939-F93B1978-210E-4C1E-9B96-3F7FCF1385E7Q55040220-D394F42E-88CA-4ED2-90B8-04972B56B9CFQ55187995-C186DE95-6F50-443F-9F82-135C900EF71EQ55464442-4C72D236-BA01-4A1B-9BE1-2B28926C192CQ58783963-42F4FAD5-CC06-4D35-9C40-E80998395DB2
P2860
Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
@ast
Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
@en
Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
@nl
type
label
Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
@ast
Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
@en
Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
@nl
prefLabel
Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
@ast
Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
@en
Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
@nl
P2860
P921
P3181
P1476
Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
@en
P2093
Robert W Mahley
P2860
P2888
P304
P3181
P356
10.1007/S00109-016-1427-Y
P407
P5008
P577
2016-07-01T00:00:00Z
P6179
1048589134